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Interventions focusing on promoting DSME and overcoming the barriers of DSME 
should be designed.  
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OBJECTIVES: This quantitative study aimed to determine the degree of 
adherence to antiretroviral therapy (ART) by recording dispensation in HIV-
infected patients attending in a reference for Secondary Center Health in 
Fortaleza, Ceará, Brazil. Monitoring of adherence should be a strategic goal in 
caring for patients infected with HIV. METHODS: A Pharmaceutical Care Service 
in José de Alencar Specialty Medical Center (JAMSC) were recruited in 100 naïve 
patients starting antiretroviral therapy between December 2008 and February 
2012. These were evaluated monthly for 09 months as adherence through the 
registry to ARV Dispensing Service Pharmacy and classified according to the 
scale of Steiner (1988) and adapted by Saldanha et al (2009) as to their profile. 
This study was approved by the Ethics Committee of the Federal University of 
Ceará. Data analyzed in Excell and SPSS®. RESULTS: The profile analysis showed 
that most patients were male (62%, n=62), single (55%, n=55) and were living with 
their family (66%, n=66). Regarding adherence, 84 patients (84%) were classified 
as Good Adherence - less than 29 days late (>95% adherence) and 06 infected 
(06%) in Critical Zone - between 29/74 days late (between 95 - 70% compliance), 
ten patients with Bad Adherence - more than 74 days late (<70% adherence) and 
no patient had more than 180 days late to receive ARVs, with no interruption of 
treatment for this classification. CONCLUSIONS: Pharmacy records are 
important indicators of potential non-adherence and should be incorporated in 
such clinical practice. The pharmaceutical and clinical attention in the care and 
treatment of the infection by the HIV should be prioritized to reach out to poor 
compliance and adherence or irregular patients with ARV pickups.  
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OBJECTIVES: To understand the levels and determinants the HIV Transition 
Clinic services utilization by young adults at Infectious Diseases Institute, 
Kampala, Uganda. METHODS: A cross sectional study using quantitative 
methods at a HTC in a sample of 379 young adults living with HIV/AIDS (YALHA) 
between the ages of 15-24 years. At analysis utilization was categorized into two 
levels; regular (kept all appointment visits) and irregular (missed one or more 
appointments visits) utilization. Univariable, bivariable and multivariable logistic 
regression was used to establish determinants associated with utilization of the 
HTC. RESULTS: Of the 379 total respondents, only 32.4% were regular utilizers of 
the HTC. There are low levels of regular utilization of the HTC. Female young 
adults have better service utilization rates compared to the males in HTC. The 
male to female ratio was 1:5. The determinants of HTC regular utilization were 
CD4 cell count category of 250-2603/μl (AOR 0.58, 95%CI: 0.36-0.95), not currently 
on ART (AOR 0.27, 95%CI: 0.15-0.47) and did not receive counseling services (AOR 
0.47, 95%CI: 0.27-0.83). CONCLUSIONS: The factors that were associated with 
reduced the chance of regular use of the HTC were: CD4 cell count between 250-
2603/μl; not being on ART; and not receiving HIV counseling services. The young 
adults in the HIV transition clinic should be screened on a regular basis to detect 
those with a CD4 cell count of <350/μl and counseled for early initiation of ART 
so as to enhance regular HIV transition clinic utilization. In addition a reminder 
system like peers, family and mobile phone messages should be set up for young 
adults so that they are reminded of their appointments hence facilitating regular 
use of the transition clinic.  
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OBJECTIVES: The methadone maintenance treatment (MMT) program has been 
implemented in Shanghai since 2005. The MMT has served to provide the 
government departments with the necessary MMT compliance and retention 
data to assist in facilitating decision-making related to the development of 
management and intervention strategies. Our study has portrayed the trend of 
MMT compliance and retention and has also served to identify related predictive 
factors of individuals enrolled in the MMT program. METHODS: A retrospective 
evaluation was performed using data from the Shanghai component of the 
National MMT data management system (a prospectively collected database) 
between January 1, 2005 and December 31, 2011. The primary outcome measured 
was the dropout of individuals from the MMT program and defined as 
methadone dosing records that were missing for >30 continuous days. A cox 
model for recurrence events was utilized in order to estimate a hazard ratio (HR) 
predicting dropout rates during the follow-up period. RESULTS: A total 6169 
individuals were cumulatively enrolled; 63% dropped out of the program at least 
once (ranging from 1 to 10 times), and 74% of them did not return until the end 
of this study. Our adjusted analyses demonstrated that the dropout occurring 
was more likely to occur among younger individuals (<30 years versus ≥50 years 
old, HR=1.48, 95%CI: 1.22-1.81), participants from ethnic minorities (HR=1.48, 95% 
CI: 1.06-2.06), those who were less educated (HR=1.31, 95%CI: 1.04-1.66), those 
sharing needles with others (HR=1.25, 95%CI: 1.01-1.53), those whose urine tested 
positive for opiates (HR=2.68, 95%CI: 2.43-2.97), and those who had a low average 
methadone dose in the initial treatment week (<20mg versus ≥60mg, HR=1.79, 
95%CI: 1.40-2.28). CONCLUSIONS: Shanghai is facing the challenge of 
maintaining a high MMT retention rate. Comprehensive interventions should be 
considered among specific populations, such as the young, poorly educated, 
opiate-positive individuals and injection drug users.  
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OBJECTIVES: To study the influence of pharmacist mediated medication 
counseling on illness related factual knowledge, perceptions, and medication 
adherence behavior in hypertensive patients of a South Indian Tertiary care 
Teaching Hospital. METHODS: The Present study was a one year prospective 
open label study. Institutional Ethical committee has approved the study. Eligible 
patients were enrolled after collecting the written informed consent. A suitably 
designed and validated KAP questionnaire was applied to assess the illness 
related factual knowledge, practices to manage the disease and its complications 
at base line and at final follow up after 120 days. Structured medication 
counseling was provided to all patients at first follow up and subsequent 3 follow 
ups. Brief Medication Questionnaire (BMQ), Pill count and Patient diary methods 
were applied at base line and subsequent follow ups of 30 days gap to assess the 
medication adherence behavior in the enrolled patients. Blood pressure was 
recorded at base line and at each follow up during the study period. Student‘t’ 
test was applied to assess the influence of medication counseling on KAP and 
medication adherence behavior. RESULTS: During the study period 76 eligible 
patients (Male: 43& female: 33) completed all the study follow ups. A highly 
significant improvement (p<0.01) in the knowledge, attitude and practice of 
patients was observed at the final follow up compared to base line. A significant 
improvement (p<0.05) was observed in all screens of BMQ and significant 
improvement (p,0.05) was observed in both systolic and diastolic blood 
pressures. CONCLUSIONS: Pharmacist mediated medication counseling has 
improved patients’ knowledge, attitude and practices towards the disease and 
medication adherence behavior and clinical outcomes  
 
PHS55  
GENERATING UTILITY VALUES FOR USE IN COST-UTILITY ANALYSES  
OF DELIRIUM INTERVENTIONS  
Meads DM1, Browne C1, Hulme CT1, Willson J1, Young J2, Sörensen-Duppils G3 
1University of Leeds, Leeds, UK, 2Bradford Institute for Health Research, Bradford, UK, 3Dalarna 
University, Falun, Sweden  
OBJECTIVES: Delirium is common in hospitalised older patients with medical 
and surgical conditions, leads to poor outcomes and is an increasing burden on 
health care resources. A systematic review yielded no utility values for this 
population. The objective was to generate utility values to parameterise cost-
utility decision models of delirium interventions in hospitalised elderly. 
METHODS: A literature review identified only one study that: a) captured 
delirium diagnoses; b) employed a multi-attribute utility (or convertible) 
measure. The study included hip fracture and hip surgery patients in Sweden 
(n=115; mean age=83) and collected SF-36 data (admission and 6 months) and 
delirium diagnoses (n=32; 12.5% of these had delirium on discharge). The study 
author supplied the data and pre- and post-delirium utility values were 
calculated using i) SF-6D conversion ii) published EQ-5D mapping algorithm. 
RESULTS: Pre-delirium utility differences between No Delirium and Delirium 
groups on admission were not in the expected direction but were non-
significant. Mean(SD) SF-6D utility values were: Admission=0.598(.115) and 
0.623(.081); 6 months=0.653(.144) and 0.618(.122), respectively for No Delirium 
and Delirium. Mapped EQ-5D scores were: Admission=0.544(.198) and 0.607(.136); 
6 months=0.645(.224) and 0.586(.189), respectively for No Delirium and Delirium. 
Mean Admission-6 month changes were: (SF-6D) 0.055 and -0.005; (EQ-5D) 0.101 
and -0.021 for No Delirium and Delirium, respectively. Thus according to both 
estimates, utility improved for those with no delirium but deteriorated for those 
who experienced delirium. CONCLUSIONS: Delirium has a lasting negative 
impact on patient utility. The utility values presented will be useful for future 
cost-utility analyses of delirium interventions targetting hip fracture. 
Assumptions are still required when populating health states and modelling 
lifetime impact as utility assessment during the delirium episode is not possible 
and longer term values are not available. Thus estimates at 1, 3 and post 6 
months would provide a fuller picture of outcomes.  
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OBJECTIVES: To assess health-utility scores associated with currently diagnosed 
PTSD, types of therapy (psychotherapy or pharmacotherapy), treatment choices 
(giving patients an opportunity to choose treatment or assigning treatment to 
patients), and treatment response. METHODS: Two hundred patients with PTSD 
enrolled in a DRPT examining the treatment and treatment-preference effects 
between prolonged exposure therapy (PE) and pharmacotherapy with sertraline 
